Which members of Congress have traded HALO?

1 member of Congress has disclosed 1 trade in Halozyme Therapeutics, Inc. (HALO) under the STOCK Act: Josh Gottheimer.

When was HALO most recently disclosed by Congress?

The most recent HALO disclosure was a purchase by Josh Gottheimer on 20 August 2021.

What is the total disclosed congressional trading volume for HALO?

Members of Congress have disclosed approximately $8K in HALO purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).

How can I track new congressional trades in HALO?

This HALO page updates as soon as new STOCK Act disclosures are filed for Halozyme Therapeutics, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS • Currently up 0.73 (+1.06%) in today's trading session

1 member of Congress has disclosed 1 trade in Halozyme Therapeutics, Inc. (HALO) via STOCK Act filings. The most recent disclosure was a purchase by Josh Gottheimer on 20 August 2021. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).

Halozyme Therapeutics, Inc. is currently trading at $69.45, positioned at 59% of its 52-week range ($51.06 – $82.22).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only

Copy Portfolio Claim Free Asset

Live portfolio tracking

Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price

$69.45

24h Change

+0.73 (+1.06%)

52 Week Range

$51.06—$82.22

View on NASDAQ

Halozyme Therapeutics, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for HALO

Select to highlight on chart

Politician

1 transactions

Include Non-Compliant

Compliance: 100%


	Josh Gottheimer	20 Aug 2021	20 Sept 2021	Purchase	Stock	$1,001 - $15,000	N/A

Select transactions to view their annotations on the chart

Earnings

Next Report

Q2 2026

4 Aug

EPS Est.

$1.85

Rev. Est.

$401.3M

Days Until

Recent Quarters

Q1 202611 May

EPS$1.60

Beat 3.9%

Q4 202517 Feb

EPS$-0.24

Miss 111.2%

Q3 20253 Nov

EPS$1.72

Beat 5.5%

Q2 20255 Aug

EPS$1.54

Beat 25.2%

Q1 20256 May

EPS$1.11

Beat 16.8%

Q4 202418 Feb

EPS$1.26

Beat 7.7%

Q3 202431 Oct

EPS$1.27

Beat 29.6%

Q2 20246 Aug

EPS$0.91

Beat 19.7%

Q1 20247 May

EPS$0.79

Beat 12.9%

Q4 202320 Feb

EPS$0.82

Miss 1.2%

Q3 20236 Nov

EPS$0.75

Beat 5.6%

Q2 20238 Aug

EPS$0.74

Beat 17.5%

Q1 20239 May

EPS$0.47

Miss 2.1%

Q4 202221 Feb

EPS$0.48

Beat 2.1%

Q3 20228 Nov

EPS$0.74

Beat 42.3%

Q2 20229 Aug

EPS$0.53

Beat 6.0%

Q1 202210 May

EPS$0.47

Miss 4.1%

Q4 202122 Feb

EPS$0.42

Beat 2.4%

Q3 20212 Nov

EPS$0.55

Beat 30.9%

Q2 20219 Aug

EPS$0.66

Beat 53.5%

Q1 202110 May

EPS$0.20

Miss 35.5%

Q4 202023 Feb

EPS$0.50

Miss 5.7%

Q3 20202 Nov

EPS$0.25

Beat 31.6%

Q2 202010 Aug

EPS$0.19

Miss 24.0%

Q1 202011 May

EPS$-0.04

Miss 300.0%

Q4 201924 Feb

EPS$-0.24

Miss 33.3%

Q3 201912 Nov

EPS$-0.17

Miss 41.7%

Q2 20196 Aug

EPS$-0.10

Beat 41.2%

Q1 20197 May

EPS$0.01

Miss 28.1%

Q4 201821 Feb

EPS$-0.01

Miss 64.5%

Q3 20186 Nov

EPS$-0.19

Beat 17.4%

Q2 20187 Aug

EPS$-0.16

Beat 27.3%

Q1 201810 May

EPS$-0.19

Beat 9.5%

Q4 201720 Feb

EPS$0.85

Beat 18.1%

Q3 20177 Nov

EPS$0.02

Beat 120.0%

Q2 20178 Aug

EPS$-0.23

Beat 8.0%

Q1 20179 May

EPS$-0.26

Miss 4.0%

Q4 201628 Feb

EPS$-0.21

Beat 30.0%

Q3 20167 Nov

EPS$-0.23

Beat 14.8%

Q2 20169 Aug

EPS$-0.21

Beat 19.2%

Q1 20169 May

EPS$-0.16

Beat 27.3%

Q4 201529 Feb

EPS$0.03

Beat 142.9%

Q3 20159 Nov

EPS$-0.19

Miss 26.7%

Q2 201510 Aug

EPS$0.02

Beat 122.2%

Q1 201511 May

EPS$-0.12

Beat 7.7%

Q4 20142 Mar

EPS$-0.04

Beat 55.6%

Q3 201410 Nov

EPS$-0.16

Beat 0.0%

Q2 201411 Aug

EPS$-0.13

Beat 27.8%

Q1 201412 May

EPS$-0.22

Miss 37.5%

Q4 201327 Feb

EPS$-0.19

Miss 11.8%

Q3 20138 Nov

EPS$-0.17

Miss 21.4%

Q2 20137 Aug

EPS$-0.20

Miss 42.9%

Q1 20138 May

EPS$-0.17

Miss 13.3%

Q4 201225 Feb

EPS$-0.04

Beat 73.3%

Q3 20128 Nov

EPS$-0.18

Miss 28.6%

Q2 20126 Aug

EPS$-0.13

Beat 13.3%

Q1 20127 May

EPS$-0.14

Miss 27.3%

Q4 20119 Mar

EPS$-0.18

Miss 20.0%

Q3 20117 Nov

EPS$0.05

Beat 221.5%

Q2 20115 Aug

EPS$0.03

Beat 123.1%

Q1 20116 May

EPS$-0.10

Beat 16.7%

Q1 20116 May

EPS$-0.10

Q3 20105 Nov

EPS$-0.13

Beat 7.1%

Q2 20106 Aug

EPS$-0.13

Beat 7.1%

Q1 20107 May

EPS$-0.13

Beat 18.8%

Q4 200912 Mar

EPS$-0.14

Beat 17.6%

Q3 20096 Nov

EPS$-0.16

Beat 11.1%

Q2 20097 Aug

EPS$-0.21

Miss 23.5%

Q1 20098 May

EPS$-0.18

Miss 12.5%

Q4 200813 Mar

EPS$-0.21

Miss 61.5%

Q3 20086 Nov

EPS$-0.14

Miss 7.7%

Q2 20088 Aug

EPS$-0.14

Miss 7.7%

Q1 20088 May

EPS$-0.13

Miss 8.3%

Q4 200713 Mar

EPS$-0.11

Miss 37.5%

Q3 20078 Nov

EPS$-0.09

Miss 50.0%

Q2 20079 Aug

EPS$-0.07

Miss 55.6%

Q1 200710 May

EPS$-0.05

Beat 0.0%

Q4 20068 Mar

EPS$-0.07

Miss 16.7%

Q3 20069 Nov

EPS$-0.06

Beat 0.0%

Q2 200610 Aug

EPS$-0.05

Beat 0.0%

Q1 200610 May

EPS$-0.06

Miss 20.0%

Q4 200523 Mar

EPS$-0.07

Miss 16.7%

Q3 200511 Nov

EPS$-0.07

Miss 16.7%

Q2 20058 Aug

EPS$-0.06

Beat 0.0%

Q1 200513 May

EPS$-0.06

Beat 0.0%

Q4 20049 Mar

EPS$-0.05

Beat 28.6%

Q3 200412 Nov

EPS$-0.08

Miss 60.0%

Q2 200416 Aug

EPS$-0.05

Miss 25.0%

Q1 20041 Jun

EPS$-0.00

Beat 88.4%

Q1 200414 May

EPS$-0.08

Q3 200314 Nov

EPS$-0.00

Q2 200314 Aug

EPS$-0.00

Q1 200319 May

EPS$-0.00

Q1 20031 May

EPS$-0.02

Q3 200214 Nov

EPS$-0.01

Q2 200219 Aug

EPS$-0.01

Q1 200215 May

EPS$0.01

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

LLY

Eli Lilly and Company

$1084.60+19.86 (+1.87%)

Healthcare

2 politicians both hold this

Same sector: Healthcare

2 politicians

View Stock

JNJ

Johnson & Johnson

$231.86+1.68 (+0.73%)

Healthcare

2 politicians both hold this

Same sector: Healthcare

2 politicians

View Stock

AAPL

Apple Inc.

$310.66+2.33 (+0.75%)

Technology

2 politicians both hold this

Significant holdings value

2 politicians

View Stock

Frequently Asked Questions about HALO

Which members of Congress have traded HALO?: 1 member of Congress has disclosed 1 trade in Halozyme Therapeutics, Inc. (HALO) under the STOCK Act: Josh Gottheimer.
When was HALO most recently disclosed by Congress?: The most recent HALO disclosure was a purchase by Josh Gottheimer on 20 August 2021.
What is the total disclosed congressional trading volume for HALO?: Members of Congress have disclosed approximately $8K in HALO purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in HALO?: This HALO page updates as soon as new STOCK Act disclosures are filed for Halozyme Therapeutics, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.

Halozyme Therapeutics, Inc. (HALO)

Want to automatically copy Pelosi trades?

Halozyme Therapeutics, Inc. Price History and Technical Analysis

Congressional Trading Activity for HALO

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Similar Stocks

LLY

JNJ

AAPL

Frequently Asked Questions about HALO

Halozyme Therapeutics, Inc. (HALO)

Want to automatically copy Pelosi trades?

Halozyme Therapeutics, Inc. Price History and Technical Analysis

Congressional Trading Activity for HALO

Stock Overview

Market Data

Fundamentals

Company Information

Earnings

Next Report

Recent Quarters

Similar Stocks

LLY

JNJ

AAPL

Frequently Asked Questions about HALO

Track HALO in Congress